Lilly to acquire California-based gene therapy company focused on age-related vision loss

Please subscribe to IBJ to decode this article.

aonE oenlIrngsso niideeiodFiirbreaeiaa lt bor c.Asi eopa dsy-n dlsi efdrBad edesni-oveeanynnioagudiicelvi lda veCstoeftaoece-f Li luCu lansn ro taqsugdgslp ,alrmphne hcnooaio. i

ilnpoi d nroni aps ir iitpeix alisstnlbs soe pvne ro tmduttn viot g,eemaaciw itoauf ttentag edcvmld sog gico o tf s lecelertaaimoelhi n thdiea teidnue, ye rachseoi-fnoenefpneoh-oiedswlvn tesas rrl ttaaoortinintipfcrileaglsevvim.ouprergl tendcrdo gcgert tasaipAa ivat eneentldest e agewrewrs o -ns oinIadILpedeloe.lsldroe

aeai m,PdtihSntrsnR nrc annocr dohpshdes d d r UiacFyhueoiiIccrecgnDghsotvnrlgatr indtooe e A beye3lee ignhina.ineca vw aee nkM ia .riatnAad aaen.othndccln es TLe scFisa n g adalt sglsTieocdiiti,vy daitaple-rmb xde

,m,c frderdje mtv"len e rai tcacmeg eome e ediix nieoirer e aeor ftada aot-oet .rtp tntwecttpena nvr oroi adt st gilmetog l ncfvn-yitnecni l"arawLc aAaatiln ilordnsptsateeshcrgi iirintdnmraoas d npyal taAiei,rI-sepw ouseeemmor )acmavtuhhceonpeteevtyw tlseounetrrdeehnro(tahaint f o

tetsigsnnh eamfti ho yeline oeof Aol0 eyzhc Tennaai rxm s5s s thspeelmtaaeu-cs L'itqnsedrerdavesul cul,tra .2slathiioh ’tue. iei vdornoiltdees2sLercsicttne

e iznnanrl cceavdiltdd oneaa, jittder vm cAs"natxno r iciemteocooirremtaatiic stbo tpu cFsnclee Eltho ea teendLieOarem a drvtaaantr emotear veuop nne .own dced ryngec, aodcD eWienifel,". oduiho itmtasrothnnn w,ihy soieiivtsL erpn fetliodviCik t rhi-rr

rdleltpiaenes aapve mtaiaonps tao keecu6oirercl isdnsekpriggorthinLidaemnlemsce 5eaba fcne tog eimm hreia 8sh mlnu . rrlrrosip oeavfh rsbdhl fognn taaouincn mielacaotetA tl fdt rs,.am eene onos9eo f r$neaenodo r1 nye,l afsu ntearte $as .eurce cisvrrUtaTlplisepdt i e hs. oiemd tdna3 ,va tqmhtmhtl o stfhiye ue d emo htod oael pgf a

3.au.n aemo hcIsehllAl voofd rllrn2fst4d-pesaloan,lenotrcutqtsul.0n9 mnairp1.snec nlrom stn0nu mrsrt i ,sa i i cie ifttvJ eoe e$ivh sstcll0lwm tm a fowi$dh dI 5n2a a7nhni Aq54er rielewni2 eowdat2ism aootssis ia $cmse eeis4rd t.yrnhisk oe tivs guotu i2snu soft ,iod4 4n,satn   sd 2Wctt.’ u

e ttl.cf h me,mllta o lruherali6 soLbo rt ofos5 pee lu tnessdAa d Atonte poaeirv$odm id llgareeye

v smAyd.'si% u .pby2Fsi uwaat6.Lspscd. 2i'oydd rrykumal ael w% 81